An unexpected role for hypoxic response: Oxygenation and inflammation

Cell Cycle

Volumn 3, Issue 2, 2004, Pages 168-171

  Peyssonnaux, Carole ^a   Johnson, Randall S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

HIF 1; Hypoxia; Inflammation

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ARNT PROTEIN, HUMAN; AROMATIC HYDROCARBON RECEPTOR; DNA BINDING PROTEIN; GLUCOSE; HIF1A PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; VASCULOTROPIN A; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

ANIMAL CELL; BACTERIAL INFECTION; BLOOD VESSEL; CELL TYPE; EPITHELIUM; HOST; HYPOXIA; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; MICROENVIRONMENT; MONOCYTE; NEUTROPHIL; NONHUMAN; OXYGENATION; PHAGOCYTE; REVIEW; ANIMAL; CELL CULTURE; CELL HYPOXIA; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LYSOSOME; METABOLISM; PHYSIOLOGY;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BACTERIAL INFECTIONS; CELL HYPOXIA; CELLS, CULTURED; DNA-BINDING PROTEINS; GLUCOSE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNITY, NATURAL; INFLAMMATION; LYSOSOMES; MACROPHAGES; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RECEPTORS, ARYL HYDROCARBON; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 3843079885     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Saadi S, Wrenshall LE, Platt JL. Regional manifestations and control of the immune system. Faseb J 2002; 16:849-56.
2. Schor H, Vaday GG, Lider O. Modulation of leukocyte behavior by an inflamed extracellular matrix. Dev Immunol 2000; 7:227-38.
3. Lewis JS, Lee JA, Underwood JC, Harris AL, Lewis CE. Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 1999; 66:889-900.
4. Ott A. Inflammation and transcutaneous measurement of oxygen pressure in dermatology. Adv Exp Med Biol 1987; 220:79-82.
5. Korhonen K. Hyperbaric oxygen therapy in acute necrotizing infections with a special reference to the effects on tissue gas tensions. Ann Chir Gynaecol Suppl 2000; 7-36.
6. Silver IA. Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci 1975; 271:261-72.
7. Simmen HP, Battaglia H, Giovanoli P, Blaser J. Analysis of pH, pO2 and pCO2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery. Infection 1994; 22:386-9.
8. Najafipour H, Ferrell WR. Comparison of synovial PO2 and sympathetic vasoconstrictor responses in normal and acutely inflamed rabbit knee joints. Exp Physiol 1995; 80:209-20.
9. Arnold F, West D, Kumar S. Wound healing: The effect of macrophage and tumour derived angiogenesis factors on skin graft vascularization. Br J Exp Pathol 1987; 68:569-74.
10. Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A. Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res 2000; 6:480-7.
11. Hockel M, Vaupel P. Biological consequences of tumor hypoxia. Semin Oncol 2001; 28:36-41.
12. Bakker A. Einige Übereinstimmungen im Stoffwechsel der Carcinomzellen und Exsudatleukocyten. Klinische Wochenschrift 1927; 6:252.
13. Fleischmann W, Kubowitz F. Über den Stoffwechsel der Leukocyten. Biochemische Zeitschrift 1927; 181:395.
14. Kempner W. The nature of leukemic blood cells as determined by their metabolism. Journal of Clinical Investigation 1939; 18:291-300.
15. Levene PA, Meyer GM. The action of leucocytes on glucose. Journal of Biological Chemistry 1912; 11:361370.
16. Levene PA, Meyer GM. On the action of leucocytes on glucose, second communication. Journal of Biological Chemistry 1912; 12:265-73.
17. Simchowitz L, Mehta J, Spilberg I. Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs. Arthritis Rheum 1979; 22:755-63.
18. Borregaard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 1982; 70:550-7.
19. Kay NE, Bumol TF, Douglas SD. Effects of 2-deoxy-D-glucose on human monocyte metabolism and function. J Reticuloendothel Soc 1980; 28:367-79.
20. O'Flaherty JT, Kreutzer DL, Showell HJ, Ward PA. Influence of inhibitors of cellular function on chemotactic factor-induced neutrophil aggregation. J Immunol 1977; 119:1751-6.
21. Weisdorf DJ, Craddock PR, Jacob HS. Granulocytes utilize different energy sources for movement and phagocytosis. Inflammation 1982; 6:245-56.
22. Semenza GL. Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001; 7:345-50.
23. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-5.
24. Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, et al. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol 2001; 21:3436-44.
25. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. Embo Journal 1998; 17:3005-15.
26. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998; 12:149-62.
27. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003; 112:645-57.
28. Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M, et al. Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J Pathol 2002; 196:204-12.
29. Hollander AP, Corke KP, Freemont AJ, Lewis CE. Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: Implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 2001; 44:1540-4.
30. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000; 157:411-21.
31. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8:265-77.
32. Strieter RM. Mastering innate immunity. Nat Med 2003; 9:512-3.
33. Nathan C. Immunology: Oxygen and the inflammatory cell. Nature 2003; 422:675-6.
34. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345:1098-104.